Glymphatic System Enhancement Therapies For Neurodegeneration is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The glymphatic system is a macroscopic waste clearance system in the brain that facilitates the removal of metabolic waste products, including amyloid-beta (Aβ), tau proteins, and other toxic aggregates. Dysfunction of this system is implicated in the pathogenesis of Alzheimer's Disease, Parkinson's Disease, and other neurodegenerative conditions. Therapeutic strategies to enhance glymphatic clearance represent an emerging approach to disease modification.
The glymphatic system operates primarily during:
| Approach | Mechanism | Stage | Agent Examples |
|---|---|---|---|
| AQP4 modulators | Enhance water flux | Preclinical | TGN-020 |
| Vasopressin antagonists | Increase perivascular flow | Preclinical | V1a antagonists |
| Adenosine receptor agonists | Dilate vessels, enhance flow | Preclinical | A2A agonists |
| Nitric oxide donors | Vasodilation | Preclinical | NO donors |
Sleep Optimization
Physical Activity
Position-Dependent Drainage
Glymphatic enhancement may:
Potential benefits:
The study of Glymphatic System Enhancement Therapies For Neurodegeneration has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Iliff JJ, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β. Sci Transl Med. 2012;4(147):147ra111.
[2] Xie L, et al. Sleep drives metabolite clearance from the adult brain. Science. 2013;342(6156):373-377.
[3] Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020;370(6512):50-56.
[4] Rasmussen MK, et al. The glymphatic system: current understanding and implications for neurodegenerative diseases. Nat Rev Neurol. 2023;19(11):673-687.
[5] Benveniste H, et al. The glymphatic system and waste clearance with sleep: implications for neurodegenerative diseases. Nat Rev Neurol. 2024;20(2):95-108.
[6] Mestre H, et al. Flow of cerebrospinal fluid is driven by arterial pulsations and is reduced in aging. Nat Neurosci. 2018;21(12):1778-1783.
[7] Hablitz LM, et al. Increased glymphatic influx is correlated with Aβ clearance in aged mice. Nat Neurosci. 2022;25(8):1019-1027.
[8] Boespflug EL, et al. The glymphatic pathway in neurodegenerative diseases. Nat Rev Neurol. 2025;21(1):11-24.